RxDoctor Payments Data

Steven Lowry, DO

Family Medicine · Williamstown, NJNPI 1285637223

Payments from drug & device makers

$9,262in general payments, 2019–2025

Across 591 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$998
  • AbbVie$766
  • Pfizer$653
  • Lilly USA, LLC$510
  • Amgen$492
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$9,262100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,262 in reported general payments places this provider in the 90th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$219,772
Medicare patients
419
Services billed
3,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate55$64,609
EliquisApixaban49$64,037
MounjaroTirzepatide27$37,285
OzempicSemaglutide20$31,682
FarxigaDapagliflozin Propanediol21$30,884
TrulicityDulaglutide12$23,716
JanumetSitagliptin Phos/Metformin Hcl11$17,787
XareltoRivaroxaban16$15,904
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$14,891
Verapamil Er PmVerapamil Hcl22$12,273
Fluticasone-SalmeterolFluticasone Propion/Salmeterol31$8,388
Atorvastatin Calcium523$4,824
SymbicortBudesonide/Formoterol Fumarate13$3,094
Fluticasone Propionate173$2,878
PaxlovidNirmatrelvir/Ritonavir19$2,838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$202$82,39666 claims
PfizerEliquis, Paxlovid$653$66,87568 claims
Lilly USA, LLCMounjaro, Trulicity$510$61,00139 claims
AstraZenecaFarxiga, Symbicort$998$33,97834 claims
Novo NordiskOzempic$1,632$31,68220 claims
Johnson & JohnsonXarelto$213$15,90416 claims
GSKTrelegy Ellipta$384$14,89112 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$2,059206 claims
AbbVieSynthroid$766$1,56521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Williamstown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →